Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Orchard Therapeutics Opens Second Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Orchard Therapeutics Opens Second Facility

The expansion quadruples their technical operation capacity

By: Betsy Louda

, Contract Pharma

Orchard Therapeutics, a clinical-stage biotechnology company, is opening a second facility for technical operations in the San Francisco Bay Area.

 

In combination with their existing site, they say the new facility quadruples Orchard’s laboratory footprint for the technical operations that support development, validation of processes, and controls for the manufacture of their gene therapy products.

 

Orchard’s pipeline includes clinical and pre-clinical stage autologous and ex-vivo lentiviral gene therapies for primary immune deficiencies and inherited metabolic disorders. Their lead product, OTL-101, is in late-stage development and is anticipated to progress to a Biological License Application with the FDA in 2018. The OTL-101 development program has received a $19 million award from the California Institute for Regenerative Medicine.


“The new facility in Menlo Park reflects the rapid growth of our pipeline of transformative gene therapies. In concert with our facility expansion, we look forward to continuing to attract first class technical and management talent to the many career opportunities we are creating in our California operation.” said Mark Rothera, president and chief executive officer of Orchard.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics